Found 38 hits with Last Name = 'delannée' and Initial = 'd' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50380669
(CHEMBL2017273)Show SMILES COc1cc2c(Nc3ccccc3F)c(cnc2cc1-c1c(C)noc1C)C(N)=O |(8.28,-47.02,;8.28,-48.56,;9.62,-49.33,;10.95,-48.56,;12.28,-49.32,;13.61,-48.55,;13.6,-47.01,;12.26,-46.24,;10.95,-47.02,;9.61,-46.27,;9.6,-44.72,;10.93,-43.94,;12.26,-44.71,;13.6,-43.93,;14.95,-49.31,;14.95,-50.86,;13.62,-51.63,;12.28,-50.86,;10.95,-51.64,;9.62,-50.87,;8.28,-51.64,;8.25,-53.18,;9.47,-54.11,;6.77,-53.63,;5.89,-52.36,;6.83,-51.14,;6.38,-49.66,;16.27,-48.53,;17.61,-49.29,;16.26,-46.99,)| Show InChI InChI=1S/C22H19FN4O3/c1-11-20(12(2)30-27-11)14-8-18-13(9-19(14)29-3)21(15(10-25-18)22(24)28)26-17-7-5-4-6-16(17)23/h4-10H,1-3H3,(H2,24,28)(H,25,26) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50380667
(CHEMBL2017268)Show SMILES Cc1noc(C)c1-c1ccc2c(Nc3ccccc3C(C)(C)C)c(cnc2c1)C(N)=O Show InChI InChI=1S/C25H26N4O2/c1-14-22(15(2)31-29-14)16-10-11-17-21(12-16)27-13-18(24(26)30)23(17)28-20-9-7-6-8-19(20)25(3,4)5/h6-13H,1-5H3,(H2,26,30)(H,27,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 700 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50380676
(CHEMBL2017283)Show SMILES COc1cc2c3n(-c4ccccc4C(C)(C)C)c(=O)[nH]c3cnc2cc1-c1c(C)noc1C |(4.94,-26.84,;4.94,-28.38,;6.27,-29.15,;7.6,-28.38,;8.94,-29.14,;10.26,-28.37,;10.57,-26.87,;9.8,-25.54,;8.27,-25.55,;7.49,-24.22,;8.26,-22.87,;9.81,-22.88,;10.57,-24.21,;12.11,-24.21,;12.1,-22.67,;13.6,-24.61,;13.44,-23.43,;12.09,-26.7,;12.85,-25.35,;12.73,-28.09,;11.6,-29.13,;11.61,-30.68,;10.27,-31.45,;8.94,-30.69,;7.61,-31.47,;6.27,-30.7,;4.94,-31.46,;4.9,-33.01,;6.13,-33.94,;3.43,-33.45,;2.55,-32.19,;3.48,-30.96,;3.03,-29.49,)| Show InChI InChI=1S/C26H26N4O3/c1-14-23(15(2)33-29-14)17-11-19-16(12-22(17)32-6)24-20(13-27-19)28-25(31)30(24)21-10-8-7-9-18(21)26(3,4)5/h7-13H,1-6H3,(H,28,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 900 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50380680
(CHEMBL2017288)Show SMILES COc1cc2c3n([C@H](C)c4ccccc4)c(=O)[nH]c3cnc2cc1-c1c(C)noc1C |r,wD:7.7,(3.4,-41.04,;3.4,-42.58,;4.73,-43.35,;6.06,-42.58,;7.4,-43.35,;8.72,-42.57,;9.03,-41.07,;8.26,-39.74,;6.72,-39.74,;9.03,-38.41,;10.56,-38.41,;11.34,-37.08,;10.57,-35.74,;9.02,-35.75,;8.25,-37.08,;10.55,-40.9,;11.31,-39.56,;11.19,-42.29,;10.06,-43.33,;10.07,-44.88,;8.73,-45.66,;7.4,-44.89,;6.07,-45.67,;4.73,-44.9,;3.4,-45.67,;3.36,-47.21,;4.59,-48.14,;1.89,-47.65,;1.01,-46.39,;1.94,-45.16,;1.49,-43.69,)| Show InChI InChI=1S/C24H22N4O3/c1-13-22(15(3)31-27-13)18-10-19-17(11-21(18)30-4)23-20(12-25-19)26-24(29)28(23)14(2)16-8-6-5-7-9-16/h5-12,14H,1-4H3,(H,26,29)/t14-/m1/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50380678
(CHEMBL2017285)Show SMILES COc1cc2c3n(Cc4ccccc4)c(=O)[nH]c3cnc2cc1-c1c(C)noc1C |(31.17,-25.51,;31.17,-27.05,;32.5,-27.82,;33.83,-27.05,;35.16,-27.81,;36.49,-27.04,;36.8,-25.54,;36.03,-24.21,;36.8,-22.87,;38.33,-22.88,;39.1,-21.55,;38.33,-20.21,;36.78,-20.22,;36.02,-21.55,;38.32,-25.37,;39.08,-24.02,;38.96,-26.76,;37.83,-27.8,;37.84,-29.35,;36.5,-30.12,;35.17,-29.36,;33.83,-30.14,;32.5,-29.37,;31.16,-30.13,;31.13,-31.68,;32.36,-32.61,;29.66,-32.12,;28.78,-30.86,;29.71,-29.63,;29.26,-28.16,)| Show InChI InChI=1S/C23H20N4O3/c1-13-21(14(2)30-26-13)17-9-18-16(10-20(17)29-3)22-19(11-24-18)25-23(28)27(22)12-15-7-5-4-6-8-15/h4-11H,12H2,1-3H3,(H,25,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50380670
(CHEMBL2017274)Show SMILES COc1cc2c(Nc3ccccc3C(C)(C)C)c(cnc2cc1-c1c(C)noc1C)C(N)=O |(23.31,-46.88,;23.31,-48.42,;24.65,-49.19,;25.97,-48.42,;27.31,-49.18,;28.64,-48.41,;28.63,-46.87,;27.29,-46.1,;25.97,-46.88,;24.64,-46.13,;24.62,-44.58,;25.96,-43.8,;27.29,-44.57,;28.62,-43.79,;29.96,-44.56,;28.62,-42.25,;29.95,-43.01,;29.97,-49.17,;29.98,-50.72,;28.65,-51.49,;27.31,-50.72,;25.98,-51.5,;24.64,-50.73,;23.31,-51.5,;23.27,-53.04,;24.5,-53.97,;21.8,-53.49,;20.92,-52.22,;21.85,-51,;21.4,-49.52,;31.3,-48.39,;32.64,-49.15,;31.29,-46.85,)| Show InChI InChI=1S/C26H28N4O3/c1-14-23(15(2)33-30-14)17-11-21-16(12-22(17)32-6)24(18(13-28-21)25(27)31)29-20-10-8-7-9-19(20)26(3,4)5/h7-13H,1-6H3,(H2,27,31)(H,28,29) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50380664
(CHEMBL2017287)Show SMILES COc1cc2c3n(C(C)c4ccccc4)c(=O)[nH]c3cnc2cc1-c1c(C)noc1C |(-7.28,-41.44,;-7.28,-42.98,;-5.94,-43.75,;-4.62,-42.98,;-3.28,-43.74,;-1.95,-42.97,;-1.65,-41.47,;-2.42,-40.14,;-3.96,-40.14,;-1.65,-38.8,;-.11,-38.81,;.66,-37.48,;-.11,-36.14,;-1.66,-36.14,;-2.42,-37.48,;-.13,-41.29,;.63,-39.95,;.51,-42.69,;-.62,-43.72,;-.61,-45.28,;-1.94,-46.05,;-3.28,-45.29,;-4.61,-46.07,;-5.95,-45.29,;-7.28,-46.06,;-7.32,-47.61,;-6.09,-48.54,;-8.79,-48.05,;-9.67,-46.79,;-8.74,-45.56,;-9.19,-44.09,)| Show InChI InChI=1S/C24H22N4O3/c1-13-22(15(3)31-27-13)18-10-19-17(11-21(18)30-4)23-20(12-25-19)26-24(29)28(23)14(2)16-8-6-5-7-9-16/h5-12,14H,1-4H3,(H,26,29) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50380680
(CHEMBL2017288)Show SMILES COc1cc2c3n([C@H](C)c4ccccc4)c(=O)[nH]c3cnc2cc1-c1c(C)noc1C |r,wD:7.7,(3.4,-41.04,;3.4,-42.58,;4.73,-43.35,;6.06,-42.58,;7.4,-43.35,;8.72,-42.57,;9.03,-41.07,;8.26,-39.74,;6.72,-39.74,;9.03,-38.41,;10.56,-38.41,;11.34,-37.08,;10.57,-35.74,;9.02,-35.75,;8.25,-37.08,;10.55,-40.9,;11.31,-39.56,;11.19,-42.29,;10.06,-43.33,;10.07,-44.88,;8.73,-45.66,;7.4,-44.89,;6.07,-45.67,;4.73,-44.9,;3.4,-45.67,;3.36,-47.21,;4.59,-48.14,;1.89,-47.65,;1.01,-46.39,;1.94,-45.16,;1.49,-43.69,)| Show InChI InChI=1S/C24H22N4O3/c1-13-22(15(3)31-27-13)18-10-19-17(11-21(18)30-4)23-20(12-25-19)26-24(29)28(23)14(2)16-8-6-5-7-9-16/h5-12,14H,1-4H3,(H,26,29)/t14-/m1/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50380673
(CHEMBL2017279)Show SMILES COc1cc2c(Nc3ccccc3N3CCOCC3)c(cnc2cc1-c1c(C)noc1C)C(N)=O |(9.05,-12.9,;9.05,-14.44,;10.38,-15.21,;11.71,-14.43,;13.04,-15.2,;14.37,-14.43,;14.36,-12.89,;13.03,-12.12,;11.71,-12.9,;10.37,-12.15,;10.36,-10.6,;11.69,-9.82,;13.03,-10.59,;14.36,-9.81,;15.69,-10.58,;17.02,-9.82,;17.02,-8.28,;15.69,-7.51,;14.35,-8.27,;15.71,-15.19,;15.72,-16.74,;14.38,-17.51,;13.05,-16.74,;11.71,-17.52,;10.38,-16.75,;9.04,-17.52,;9.01,-19.06,;10.24,-19.99,;7.54,-19.51,;6.66,-18.24,;7.59,-17.02,;7.14,-15.54,;17.04,-14.41,;18.37,-15.17,;17.03,-12.87,)| Show InChI InChI=1S/C26H27N5O4/c1-15-24(16(2)35-30-15)18-12-21-17(13-23(18)33-3)25(19(14-28-21)26(27)32)29-20-6-4-5-7-22(20)31-8-10-34-11-9-31/h4-7,12-14H,8-11H2,1-3H3,(H2,27,32)(H,28,29) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50380676
(CHEMBL2017283)Show SMILES COc1cc2c3n(-c4ccccc4C(C)(C)C)c(=O)[nH]c3cnc2cc1-c1c(C)noc1C |(4.94,-26.84,;4.94,-28.38,;6.27,-29.15,;7.6,-28.38,;8.94,-29.14,;10.26,-28.37,;10.57,-26.87,;9.8,-25.54,;8.27,-25.55,;7.49,-24.22,;8.26,-22.87,;9.81,-22.88,;10.57,-24.21,;12.11,-24.21,;12.1,-22.67,;13.6,-24.61,;13.44,-23.43,;12.09,-26.7,;12.85,-25.35,;12.73,-28.09,;11.6,-29.13,;11.61,-30.68,;10.27,-31.45,;8.94,-30.69,;7.61,-31.47,;6.27,-30.7,;4.94,-31.46,;4.9,-33.01,;6.13,-33.94,;3.43,-33.45,;2.55,-32.19,;3.48,-30.96,;3.03,-29.49,)| Show InChI InChI=1S/C26H26N4O3/c1-14-23(15(2)33-29-14)17-11-19-16(12-22(17)32-6)24-20(13-27-19)28-25(31)30(24)21-10-8-7-9-18(21)26(3,4)5/h7-13H,1-6H3,(H,28,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50380674
(CHEMBL2017280)Show SMILES COc1cc2c(Nc3ccccc3C(=O)N3CCCCC3)c(cnc2cc1-c1c(C)noc1C)C(N)=O |(24.43,-12.31,;24.43,-13.85,;25.77,-14.62,;27.09,-13.85,;28.43,-14.62,;29.76,-13.84,;29.75,-12.3,;28.41,-11.54,;27.09,-12.32,;25.76,-11.56,;25.74,-10.02,;27.08,-9.24,;28.41,-10,;29.74,-9.23,;31.07,-10,;29.74,-7.69,;31.08,-6.93,;31.08,-5.39,;29.75,-4.62,;28.41,-5.38,;28.41,-6.93,;31.09,-14.6,;31.1,-16.15,;29.77,-16.93,;28.43,-16.16,;27.1,-16.94,;25.76,-16.17,;24.43,-16.93,;24.39,-18.48,;25.62,-19.41,;22.92,-18.92,;22.04,-17.66,;22.97,-16.43,;22.52,-14.96,;32.42,-13.82,;33.76,-14.59,;32.41,-12.28,)| Show InChI InChI=1S/C28H29N5O4/c1-16-25(17(2)37-32-16)20-13-23-19(14-24(20)36-3)26(21(15-30-23)27(29)34)31-22-10-6-5-9-18(22)28(35)33-11-7-4-8-12-33/h5-6,9-10,13-15H,4,7-8,11-12H2,1-3H3,(H2,29,34)(H,30,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50380671
(CHEMBL2017275)Show SMILES COc1cc2c(Nc3ccccc3CCN3CCOCC3)c(cnc2cc1-c1c(C)noc1C)C(N)=O |(-7.39,1.64,;-7.39,.1,;-6.05,-.67,;-4.72,.1,;-3.39,-.66,;-2.06,.11,;-2.07,1.65,;-3.41,2.41,;-4.72,1.63,;-6.06,2.39,;-6.07,3.94,;-4.74,4.71,;-3.41,3.95,;-2.07,4.72,;-.74,3.96,;.59,4.73,;1.93,3.95,;3.26,4.72,;3.27,6.26,;1.93,7.03,;.59,6.26,;-.73,-.65,;-.72,-2.2,;-2.05,-2.97,;-3.39,-2.21,;-4.72,-2.98,;-6.06,-2.21,;-7.39,-2.98,;-7.42,-4.52,;-6.2,-5.46,;-8.9,-4.97,;-9.78,-3.71,;-8.85,-2.48,;-9.29,-1.01,;.6,.13,;1.94,-.63,;.59,1.67,)| Show InChI InChI=1S/C28H31N5O4/c1-17-26(18(2)37-32-17)21-14-24-20(15-25(21)35-3)27(22(16-30-24)28(29)34)31-23-7-5-4-6-19(23)8-9-33-10-12-36-13-11-33/h4-7,14-16H,8-13H2,1-3H3,(H2,29,34)(H,30,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50380670
(CHEMBL2017274)Show SMILES COc1cc2c(Nc3ccccc3C(C)(C)C)c(cnc2cc1-c1c(C)noc1C)C(N)=O |(23.31,-46.88,;23.31,-48.42,;24.65,-49.19,;25.97,-48.42,;27.31,-49.18,;28.64,-48.41,;28.63,-46.87,;27.29,-46.1,;25.97,-46.88,;24.64,-46.13,;24.62,-44.58,;25.96,-43.8,;27.29,-44.57,;28.62,-43.79,;29.96,-44.56,;28.62,-42.25,;29.95,-43.01,;29.97,-49.17,;29.98,-50.72,;28.65,-51.49,;27.31,-50.72,;25.98,-51.5,;24.64,-50.73,;23.31,-51.5,;23.27,-53.04,;24.5,-53.97,;21.8,-53.49,;20.92,-52.22,;21.85,-51,;21.4,-49.52,;31.3,-48.39,;32.64,-49.15,;31.29,-46.85,)| Show InChI InChI=1S/C26H28N4O3/c1-14-23(15(2)33-30-14)17-11-21-16(12-22(17)32-6)24(18(13-28-21)25(27)31)29-20-10-8-7-9-19(20)26(3,4)5/h7-13H,1-6H3,(H2,27,31)(H,28,29) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50380677
(CHEMBL2017284)Show SMILES COc1cc2c3n(-c4ccccc4OC(F)(F)F)c(=O)[nH]c3cnc2cc1-c1c(C)noc1C |(17.24,-27.14,;17.24,-28.68,;18.57,-29.45,;19.9,-28.68,;21.23,-29.44,;22.56,-28.67,;22.87,-27.17,;22.1,-25.83,;20.56,-25.84,;19.79,-24.51,;20.56,-23.17,;22.1,-23.17,;22.87,-24.5,;24.41,-24.51,;25.18,-23.18,;26.72,-23.18,;24.42,-21.84,;25.94,-21.83,;24.39,-26.99,;25.15,-25.65,;25.03,-28.39,;23.9,-29.42,;23.91,-30.98,;22.57,-31.75,;21.24,-30.98,;19.9,-31.76,;18.57,-30.99,;17.23,-31.76,;17.2,-33.3,;18.43,-34.23,;15.73,-33.75,;14.85,-32.48,;15.78,-31.26,;15.33,-29.78,)| Show InChI InChI=1S/C23H17F3N4O4/c1-11-20(12(2)34-29-11)14-8-15-13(9-19(14)32-3)21-16(10-27-15)28-22(31)30(21)17-6-4-5-7-18(17)33-23(24,25)26/h4-10H,1-3H3,(H,28,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50380667
(CHEMBL2017268)Show SMILES Cc1noc(C)c1-c1ccc2c(Nc3ccccc3C(C)(C)C)c(cnc2c1)C(N)=O Show InChI InChI=1S/C25H26N4O2/c1-14-22(15(2)31-29-14)16-10-11-17-21(12-16)27-13-18(24(26)30)23(17)28-20-9-7-6-8-19(20)25(3,4)5/h6-13H,1-5H3,(H2,26,30)(H,27,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50380664
(CHEMBL2017287)Show SMILES COc1cc2c3n(C(C)c4ccccc4)c(=O)[nH]c3cnc2cc1-c1c(C)noc1C |(-7.28,-41.44,;-7.28,-42.98,;-5.94,-43.75,;-4.62,-42.98,;-3.28,-43.74,;-1.95,-42.97,;-1.65,-41.47,;-2.42,-40.14,;-3.96,-40.14,;-1.65,-38.8,;-.11,-38.81,;.66,-37.48,;-.11,-36.14,;-1.66,-36.14,;-2.42,-37.48,;-.13,-41.29,;.63,-39.95,;.51,-42.69,;-.62,-43.72,;-.61,-45.28,;-1.94,-46.05,;-3.28,-45.29,;-4.61,-46.07,;-5.95,-45.29,;-7.28,-46.06,;-7.32,-47.61,;-6.09,-48.54,;-8.79,-48.05,;-9.67,-46.79,;-8.74,-45.56,;-9.19,-44.09,)| Show InChI InChI=1S/C24H22N4O3/c1-13-22(15(3)31-27-13)18-10-19-17(11-21(18)30-4)23-20(12-25-19)26-24(29)28(23)14(2)16-8-6-5-7-9-16/h5-12,14H,1-4H3,(H,26,29) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50380665
(CHEMBL2017089)Show SMILES Cc1noc(C)c1-c1ccc2c(Nc3ccccc3)c(cnc2c1)C(N)=O Show InChI InChI=1S/C21H18N4O2/c1-12-19(13(2)27-25-12)14-8-9-16-18(10-14)23-11-17(21(22)26)20(16)24-15-6-4-3-5-7-15/h3-11H,1-2H3,(H2,22,26)(H,23,24) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50380671
(CHEMBL2017275)Show SMILES COc1cc2c(Nc3ccccc3CCN3CCOCC3)c(cnc2cc1-c1c(C)noc1C)C(N)=O |(-7.39,1.64,;-7.39,.1,;-6.05,-.67,;-4.72,.1,;-3.39,-.66,;-2.06,.11,;-2.07,1.65,;-3.41,2.41,;-4.72,1.63,;-6.06,2.39,;-6.07,3.94,;-4.74,4.71,;-3.41,3.95,;-2.07,4.72,;-.74,3.96,;.59,4.73,;1.93,3.95,;3.26,4.72,;3.27,6.26,;1.93,7.03,;.59,6.26,;-.73,-.65,;-.72,-2.2,;-2.05,-2.97,;-3.39,-2.21,;-4.72,-2.98,;-6.06,-2.21,;-7.39,-2.98,;-7.42,-4.52,;-6.2,-5.46,;-8.9,-4.97,;-9.78,-3.71,;-8.85,-2.48,;-9.29,-1.01,;.6,.13,;1.94,-.63,;.59,1.67,)| Show InChI InChI=1S/C28H31N5O4/c1-17-26(18(2)37-32-17)21-14-24-20(15-25(21)35-3)27(22(16-30-24)28(29)34)31-23-7-5-4-6-19(23)8-9-33-10-12-36-13-11-33/h4-7,14-16H,8-13H2,1-3H3,(H2,29,34)(H,30,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50380677
(CHEMBL2017284)Show SMILES COc1cc2c3n(-c4ccccc4OC(F)(F)F)c(=O)[nH]c3cnc2cc1-c1c(C)noc1C |(17.24,-27.14,;17.24,-28.68,;18.57,-29.45,;19.9,-28.68,;21.23,-29.44,;22.56,-28.67,;22.87,-27.17,;22.1,-25.83,;20.56,-25.84,;19.79,-24.51,;20.56,-23.17,;22.1,-23.17,;22.87,-24.5,;24.41,-24.51,;25.18,-23.18,;26.72,-23.18,;24.42,-21.84,;25.94,-21.83,;24.39,-26.99,;25.15,-25.65,;25.03,-28.39,;23.9,-29.42,;23.91,-30.98,;22.57,-31.75,;21.24,-30.98,;19.9,-31.76,;18.57,-30.99,;17.23,-31.76,;17.2,-33.3,;18.43,-34.23,;15.73,-33.75,;14.85,-32.48,;15.78,-31.26,;15.33,-29.78,)| Show InChI InChI=1S/C23H17F3N4O4/c1-11-20(12(2)34-29-11)14-8-15-13(9-19(14)32-3)21-16(10-27-15)28-22(31)30(21)17-6-4-5-7-18(17)33-23(24,25)26/h4-10H,1-3H3,(H,28,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50380681
(CHEMBL2017290)Show SMILES CC[C@H](c1ccccc1)n1c2c(cnc3cc(-c4c(C)noc4C)c(OC)cc23)[nH]c1=O |r,wD:2.9,(32.31,-39.16,;33.08,-40.49,;34.62,-40.49,;35.39,-39.16,;36.92,-39.16,;37.69,-37.83,;36.92,-36.5,;35.38,-36.5,;34.61,-37.83,;35.39,-41.83,;35.08,-43.33,;36.42,-44.08,;36.43,-45.64,;35.09,-46.41,;33.76,-45.64,;32.43,-46.42,;31.09,-45.65,;29.76,-46.42,;29.72,-47.96,;30.95,-48.89,;28.25,-48.41,;27.37,-47.14,;28.3,-45.92,;27.85,-44.44,;31.09,-44.11,;29.76,-43.34,;29.76,-41.8,;32.42,-43.34,;33.76,-44.1,;37.55,-43.05,;36.91,-41.65,;37.67,-40.31,)| Show InChI InChI=1S/C25H24N4O3/c1-5-21(16-9-7-6-8-10-16)29-24-17-12-22(31-4)18(23-14(2)28-32-15(23)3)11-19(17)26-13-20(24)27-25(29)30/h6-13,21H,5H2,1-4H3,(H,27,30)/t21-/m1/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50380681
(CHEMBL2017290)Show SMILES CC[C@H](c1ccccc1)n1c2c(cnc3cc(-c4c(C)noc4C)c(OC)cc23)[nH]c1=O |r,wD:2.9,(32.31,-39.16,;33.08,-40.49,;34.62,-40.49,;35.39,-39.16,;36.92,-39.16,;37.69,-37.83,;36.92,-36.5,;35.38,-36.5,;34.61,-37.83,;35.39,-41.83,;35.08,-43.33,;36.42,-44.08,;36.43,-45.64,;35.09,-46.41,;33.76,-45.64,;32.43,-46.42,;31.09,-45.65,;29.76,-46.42,;29.72,-47.96,;30.95,-48.89,;28.25,-48.41,;27.37,-47.14,;28.3,-45.92,;27.85,-44.44,;31.09,-44.11,;29.76,-43.34,;29.76,-41.8,;32.42,-43.34,;33.76,-44.1,;37.55,-43.05,;36.91,-41.65,;37.67,-40.31,)| Show InChI InChI=1S/C25H24N4O3/c1-5-21(16-9-7-6-8-10-16)29-24-17-12-22(31-4)18(23-14(2)28-32-15(23)3)11-19(17)26-13-20(24)27-25(29)30/h6-13,21H,5H2,1-4H3,(H,27,30)/t21-/m1/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50380675
(CHEMBL2017281)Show SMILES COc1cc2c(Nc3cccc4cccnc34)c(cnc2cc1-c1c(C)noc1C)C(N)=O |(39.67,-12.44,;39.67,-13.98,;41,-14.75,;42.33,-13.98,;43.67,-14.75,;44.99,-13.97,;44.98,-12.43,;43.65,-11.67,;42.33,-12.45,;40.99,-11.7,;40.98,-10.15,;42.31,-9.37,;42.3,-7.85,;43.62,-7.07,;44.96,-7.83,;44.97,-9.37,;43.64,-10.14,;46.33,-14.73,;46.34,-16.28,;45,-17.06,;43.67,-16.29,;42.33,-17.07,;41,-16.3,;39.67,-17.07,;39.63,-18.61,;40.86,-19.54,;38.16,-19.06,;37.28,-17.79,;38.21,-16.56,;37.76,-15.09,;47.66,-13.96,;49,-14.72,;47.65,-12.42,)| Show InChI InChI=1S/C25H21N5O3/c1-13-22(14(2)33-30-13)17-10-20-16(11-21(17)32-3)24(18(12-28-20)25(26)31)29-19-8-4-6-15-7-5-9-27-23(15)19/h4-12H,1-3H3,(H2,26,31)(H,28,29) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50380672
(CHEMBL2017276)Show SMILES COc1cc2c(Nc3ccccc3C(=O)c3ccccn3)c(cnc2cc1-c1c(C)noc1C)C(N)=O |(7.23,1.46,;7.23,-.08,;8.56,-.85,;9.89,-.08,;11.22,-.84,;12.55,-.07,;12.54,1.47,;11.21,2.24,;9.89,1.45,;8.55,2.21,;8.54,3.76,;9.87,4.53,;11.21,3.77,;12.54,4.54,;13.87,3.78,;12.54,6.08,;11.2,6.84,;11.19,8.39,;12.53,9.17,;13.87,8.39,;13.87,6.85,;13.89,-.83,;13.9,-2.38,;12.56,-3.15,;11.23,-2.38,;9.89,-3.16,;8.56,-2.39,;7.22,-3.16,;7.19,-4.7,;8.42,-5.63,;5.72,-5.15,;4.84,-3.88,;5.77,-2.66,;5.32,-1.18,;15.22,-.05,;16.55,-.81,;15.21,1.49,)| Show InChI InChI=1S/C28H23N5O4/c1-15-25(16(2)37-33-15)19-12-23-18(13-24(19)36-3)26(20(14-31-23)28(29)35)32-21-9-5-4-8-17(21)27(34)22-10-6-7-11-30-22/h4-14H,1-3H3,(H2,29,35)(H,31,32) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50380678
(CHEMBL2017285)Show SMILES COc1cc2c3n(Cc4ccccc4)c(=O)[nH]c3cnc2cc1-c1c(C)noc1C |(31.17,-25.51,;31.17,-27.05,;32.5,-27.82,;33.83,-27.05,;35.16,-27.81,;36.49,-27.04,;36.8,-25.54,;36.03,-24.21,;36.8,-22.87,;38.33,-22.88,;39.1,-21.55,;38.33,-20.21,;36.78,-20.22,;36.02,-21.55,;38.32,-25.37,;39.08,-24.02,;38.96,-26.76,;37.83,-27.8,;37.84,-29.35,;36.5,-30.12,;35.17,-29.36,;33.83,-30.14,;32.5,-29.37,;31.16,-30.13,;31.13,-31.68,;32.36,-32.61,;29.66,-32.12,;28.78,-30.86,;29.71,-29.63,;29.26,-28.16,)| Show InChI InChI=1S/C23H20N4O3/c1-13-21(14(2)30-26-13)17-9-18-16(10-20(17)29-3)22-19(11-24-18)25-23(28)27(22)12-15-7-5-4-6-8-15/h4-11H,12H2,1-3H3,(H,25,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50380675
(CHEMBL2017281)Show SMILES COc1cc2c(Nc3cccc4cccnc34)c(cnc2cc1-c1c(C)noc1C)C(N)=O |(39.67,-12.44,;39.67,-13.98,;41,-14.75,;42.33,-13.98,;43.67,-14.75,;44.99,-13.97,;44.98,-12.43,;43.65,-11.67,;42.33,-12.45,;40.99,-11.7,;40.98,-10.15,;42.31,-9.37,;42.3,-7.85,;43.62,-7.07,;44.96,-7.83,;44.97,-9.37,;43.64,-10.14,;46.33,-14.73,;46.34,-16.28,;45,-17.06,;43.67,-16.29,;42.33,-17.07,;41,-16.3,;39.67,-17.07,;39.63,-18.61,;40.86,-19.54,;38.16,-19.06,;37.28,-17.79,;38.21,-16.56,;37.76,-15.09,;47.66,-13.96,;49,-14.72,;47.65,-12.42,)| Show InChI InChI=1S/C25H21N5O3/c1-13-22(14(2)33-30-13)17-10-20-16(11-21(17)32-3)24(18(12-28-20)25(26)31)29-19-8-4-6-15-7-5-9-27-23(15)19/h4-12H,1-3H3,(H2,26,31)(H,28,29) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50380669
(CHEMBL2017273)Show SMILES COc1cc2c(Nc3ccccc3F)c(cnc2cc1-c1c(C)noc1C)C(N)=O |(8.28,-47.02,;8.28,-48.56,;9.62,-49.33,;10.95,-48.56,;12.28,-49.32,;13.61,-48.55,;13.6,-47.01,;12.26,-46.24,;10.95,-47.02,;9.61,-46.27,;9.6,-44.72,;10.93,-43.94,;12.26,-44.71,;13.6,-43.93,;14.95,-49.31,;14.95,-50.86,;13.62,-51.63,;12.28,-50.86,;10.95,-51.64,;9.62,-50.87,;8.28,-51.64,;8.25,-53.18,;9.47,-54.11,;6.77,-53.63,;5.89,-52.36,;6.83,-51.14,;6.38,-49.66,;16.27,-48.53,;17.61,-49.29,;16.26,-46.99,)| Show InChI InChI=1S/C22H19FN4O3/c1-11-20(12(2)30-27-11)14-8-18-13(9-19(14)29-3)21(15(10-25-18)22(24)28)26-17-7-5-4-6-16(17)23/h4-10H,1-3H3,(H2,24,28)(H,25,26) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 4.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50380673
(CHEMBL2017279)Show SMILES COc1cc2c(Nc3ccccc3N3CCOCC3)c(cnc2cc1-c1c(C)noc1C)C(N)=O |(9.05,-12.9,;9.05,-14.44,;10.38,-15.21,;11.71,-14.43,;13.04,-15.2,;14.37,-14.43,;14.36,-12.89,;13.03,-12.12,;11.71,-12.9,;10.37,-12.15,;10.36,-10.6,;11.69,-9.82,;13.03,-10.59,;14.36,-9.81,;15.69,-10.58,;17.02,-9.82,;17.02,-8.28,;15.69,-7.51,;14.35,-8.27,;15.71,-15.19,;15.72,-16.74,;14.38,-17.51,;13.05,-16.74,;11.71,-17.52,;10.38,-16.75,;9.04,-17.52,;9.01,-19.06,;10.24,-19.99,;7.54,-19.51,;6.66,-18.24,;7.59,-17.02,;7.14,-15.54,;17.04,-14.41,;18.37,-15.17,;17.03,-12.87,)| Show InChI InChI=1S/C26H27N5O4/c1-15-24(16(2)35-30-15)18-12-21-17(13-23(18)33-3)25(19(14-28-21)26(27)32)29-20-6-4-5-7-22(20)31-8-10-34-11-9-31/h4-7,12-14H,8-11H2,1-3H3,(H2,27,32)(H,28,29) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 5.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50380674
(CHEMBL2017280)Show SMILES COc1cc2c(Nc3ccccc3C(=O)N3CCCCC3)c(cnc2cc1-c1c(C)noc1C)C(N)=O |(24.43,-12.31,;24.43,-13.85,;25.77,-14.62,;27.09,-13.85,;28.43,-14.62,;29.76,-13.84,;29.75,-12.3,;28.41,-11.54,;27.09,-12.32,;25.76,-11.56,;25.74,-10.02,;27.08,-9.24,;28.41,-10,;29.74,-9.23,;31.07,-10,;29.74,-7.69,;31.08,-6.93,;31.08,-5.39,;29.75,-4.62,;28.41,-5.38,;28.41,-6.93,;31.09,-14.6,;31.1,-16.15,;29.77,-16.93,;28.43,-16.16,;27.1,-16.94,;25.76,-16.17,;24.43,-16.93,;24.39,-18.48,;25.62,-19.41,;22.92,-18.92,;22.04,-17.66,;22.97,-16.43,;22.52,-14.96,;32.42,-13.82,;33.76,-14.59,;32.41,-12.28,)| Show InChI InChI=1S/C28H29N5O4/c1-16-25(17(2)37-32-16)20-13-23-19(14-24(20)36-3)26(21(15-30-23)27(29)34)31-22-10-6-5-9-18(22)28(35)33-11-7-4-8-12-33/h5-6,9-10,13-15H,4,7-8,11-12H2,1-3H3,(H2,29,34)(H,30,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 8.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50380682
(CHEMBL2017291 | I-BET151 (16))Show SMILES COc1cc2c3n([C@H](C)c4ccccn4)c(=O)[nH]c3cnc2cc1-c1c(C)noc1C |r,wD:7.7,(46.55,-39.62,;46.55,-41.16,;47.89,-41.93,;49.21,-41.16,;50.55,-41.92,;51.88,-41.15,;52.18,-39.65,;51.41,-38.32,;49.87,-38.32,;52.18,-36.98,;51.41,-35.66,;52.17,-34.32,;53.72,-34.32,;54.49,-35.66,;53.72,-36.99,;53.7,-39.47,;54.46,-38.13,;54.34,-40.87,;53.21,-41.9,;53.22,-43.46,;51.89,-44.23,;50.55,-43.47,;49.22,-44.25,;47.88,-43.47,;46.55,-44.24,;46.51,-45.79,;47.74,-46.72,;45.04,-46.23,;44.16,-44.97,;45.09,-43.74,;44.64,-42.27,)| Show InChI InChI=1S/C23H21N5O3/c1-12-21(14(3)31-27-12)16-9-18-15(10-20(16)30-4)22-19(11-25-18)26-23(29)28(22)13(2)17-7-5-6-8-24-17/h5-11,13H,1-4H3,(H,26,29)/t13-/m1/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Similars
| Article
PubMed
| n/a | n/a | 9.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50380679
(CHEMBL2017286)Show SMILES COc1cc2c3n(Cc4ccccn4)c(=O)[nH]c3cnc2cc1-c1c(C)noc1C |(44.75,-24.87,;44.75,-26.41,;46.08,-27.18,;47.41,-26.4,;48.74,-27.17,;50.07,-26.4,;50.38,-24.89,;49.61,-23.56,;50.38,-22.23,;49.6,-20.9,;50.36,-19.57,;51.91,-19.57,;52.68,-20.9,;51.91,-22.23,;51.9,-24.72,;52.66,-23.38,;52.54,-26.11,;51.41,-27.15,;51.42,-28.71,;50.08,-29.48,;48.75,-28.71,;47.41,-29.49,;46.08,-28.72,;44.74,-29.49,;44.71,-31.03,;45.94,-31.96,;43.24,-31.48,;42.36,-30.21,;43.29,-28.99,;42.84,-27.51,)| Show InChI InChI=1S/C22H19N5O3/c1-12-20(13(2)30-26-12)16-8-17-15(9-19(16)29-3)21-18(10-24-17)25-22(28)27(21)11-14-6-4-5-7-23-14/h4-10H,11H2,1-3H3,(H,25,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 9.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50380682
(CHEMBL2017291 | I-BET151 (16))Show SMILES COc1cc2c3n([C@H](C)c4ccccn4)c(=O)[nH]c3cnc2cc1-c1c(C)noc1C |r,wD:7.7,(46.55,-39.62,;46.55,-41.16,;47.89,-41.93,;49.21,-41.16,;50.55,-41.92,;51.88,-41.15,;52.18,-39.65,;51.41,-38.32,;49.87,-38.32,;52.18,-36.98,;51.41,-35.66,;52.17,-34.32,;53.72,-34.32,;54.49,-35.66,;53.72,-36.99,;53.7,-39.47,;54.46,-38.13,;54.34,-40.87,;53.21,-41.9,;53.22,-43.46,;51.89,-44.23,;50.55,-43.47,;49.22,-44.25,;47.88,-43.47,;46.55,-44.24,;46.51,-45.79,;47.74,-46.72,;45.04,-46.23,;44.16,-44.97,;45.09,-43.74,;44.64,-42.27,)| Show InChI InChI=1S/C23H21N5O3/c1-12-21(14(3)31-27-12)16-9-18-15(10-20(16)30-4)22-19(11-25-18)26-23(29)28(22)13(2)17-7-5-6-8-24-17/h5-11,13H,1-4H3,(H,26,29)/t13-/m1/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Similars
| Article
PubMed
| n/a | n/a | 9.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50380672
(CHEMBL2017276)Show SMILES COc1cc2c(Nc3ccccc3C(=O)c3ccccn3)c(cnc2cc1-c1c(C)noc1C)C(N)=O |(7.23,1.46,;7.23,-.08,;8.56,-.85,;9.89,-.08,;11.22,-.84,;12.55,-.07,;12.54,1.47,;11.21,2.24,;9.89,1.45,;8.55,2.21,;8.54,3.76,;9.87,4.53,;11.21,3.77,;12.54,4.54,;13.87,3.78,;12.54,6.08,;11.2,6.84,;11.19,8.39,;12.53,9.17,;13.87,8.39,;13.87,6.85,;13.89,-.83,;13.9,-2.38,;12.56,-3.15,;11.23,-2.38,;9.89,-3.16,;8.56,-2.39,;7.22,-3.16,;7.19,-4.7,;8.42,-5.63,;5.72,-5.15,;4.84,-3.88,;5.77,-2.66,;5.32,-1.18,;15.22,-.05,;16.55,-.81,;15.21,1.49,)| Show InChI InChI=1S/C28H23N5O4/c1-15-25(16(2)37-33-15)19-12-23-18(13-24(19)36-3)26(20(14-31-23)28(29)35)32-21-9-5-4-8-17(21)27(34)22-10-6-7-11-30-22/h4-14H,1-3H3,(H2,29,35)(H,31,32) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 9.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50380668
(CHEMBL2017269)Show SMILES Cc1noc(C)c1-c1ccc2c(Nc3ccccc3C(C)(C)C)c(cnc2c1)C(O)=O Show InChI InChI=1S/C25H25N3O3/c1-14-22(15(2)31-28-14)16-10-11-17-21(12-16)26-13-18(24(29)30)23(17)27-20-9-7-6-8-19(20)25(3,4)5/h6-13H,1-5H3,(H,26,27)(H,29,30) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
MMDB
PC cid
PC sid
PDB
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50380679
(CHEMBL2017286)Show SMILES COc1cc2c3n(Cc4ccccn4)c(=O)[nH]c3cnc2cc1-c1c(C)noc1C |(44.75,-24.87,;44.75,-26.41,;46.08,-27.18,;47.41,-26.4,;48.74,-27.17,;50.07,-26.4,;50.38,-24.89,;49.61,-23.56,;50.38,-22.23,;49.6,-20.9,;50.36,-19.57,;51.91,-19.57,;52.68,-20.9,;51.91,-22.23,;51.9,-24.72,;52.66,-23.38,;52.54,-26.11,;51.41,-27.15,;51.42,-28.71,;50.08,-29.48,;48.75,-28.71,;47.41,-29.49,;46.08,-28.72,;44.74,-29.49,;44.71,-31.03,;45.94,-31.96,;43.24,-31.48,;42.36,-30.21,;43.29,-28.99,;42.84,-27.51,)| Show InChI InChI=1S/C22H19N5O3/c1-12-20(13(2)30-26-12)16-8-17-15(9-19(16)29-3)21-18(10-24-17)25-22(28)27(21)11-14-6-4-5-7-23-14/h4-10H,11H2,1-3H3,(H,25,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.29E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50380668
(CHEMBL2017269)Show SMILES Cc1noc(C)c1-c1ccc2c(Nc3ccccc3C(C)(C)C)c(cnc2c1)C(O)=O Show InChI InChI=1S/C25H25N3O3/c1-14-22(15(2)31-28-14)16-10-11-17-21(12-16)26-13-18(24(29)30)23(17)27-20-9-7-6-8-19(20)25(3,4)5/h6-13H,1-5H3,(H,26,27)(H,29,30) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
MMDB
PC cid
PC sid
PDB
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50380665
(CHEMBL2017089)Show SMILES Cc1noc(C)c1-c1ccc2c(Nc3ccccc3)c(cnc2c1)C(N)=O Show InChI InChI=1S/C21H18N4O2/c1-12-19(13(2)27-25-12)14-8-9-16-18(10-14)23-11-17(21(22)26)20(16)24-15-6-4-3-5-7-15/h3-11H,1-2H3,(H2,22,26)(H,23,24) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50380666
(CHEMBL2017091)Show SMILES Cc1noc(C)c1-c1ccc2c(Nc3ccccc3)c(cnc2c1)C(O)=O Show InChI InChI=1S/C21H17N3O3/c1-12-19(13(2)27-24-12)14-8-9-16-18(10-14)22-11-17(21(25)26)20(16)23-15-6-4-3-5-7-15/h3-11H,1-2H3,(H,22,23)(H,25,26) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50380666
(CHEMBL2017091)Show SMILES Cc1noc(C)c1-c1ccc2c(Nc3ccccc3)c(cnc2c1)C(O)=O Show InChI InChI=1S/C21H17N3O3/c1-12-19(13(2)27-24-12)14-8-9-16-18(10-14)22-11-17(21(25)26)20(16)23-15-6-4-3-5-7-15/h3-11H,1-2H3,(H,22,23)(H,25,26) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 22: 2963-7 (2012)
Article DOI: 10.1016/j.bmcl.2012.01.125
BindingDB Entry DOI: 10.7270/Q2ZC83VK |
More data for this
Ligand-Target Pair | |
Search and Browse
